Correlation Between Hansa Biopharma and Fluoguide

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hansa Biopharma and Fluoguide at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hansa Biopharma and Fluoguide into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hansa Biopharma AB and Fluoguide AS, you can compare the effects of market volatilities on Hansa Biopharma and Fluoguide and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hansa Biopharma with a short position of Fluoguide. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hansa Biopharma and Fluoguide.

Diversification Opportunities for Hansa Biopharma and Fluoguide

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Hansa and Fluoguide is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Hansa Biopharma AB and Fluoguide AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fluoguide AS and Hansa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hansa Biopharma AB are associated (or correlated) with Fluoguide. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fluoguide AS has no effect on the direction of Hansa Biopharma i.e., Hansa Biopharma and Fluoguide go up and down completely randomly.

Pair Corralation between Hansa Biopharma and Fluoguide

Assuming the 90 days trading horizon Hansa Biopharma AB is expected to under-perform the Fluoguide. In addition to that, Hansa Biopharma is 1.42 times more volatile than Fluoguide AS. It trades about -0.26 of its total potential returns per unit of risk. Fluoguide AS is currently generating about -0.09 per unit of volatility. If you would invest  4,825  in Fluoguide AS on November 28, 2024 and sell it today you would lose (385.00) from holding Fluoguide AS or give up 7.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Hansa Biopharma AB  vs.  Fluoguide AS

 Performance 
       Timeline  
Hansa Biopharma AB 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Hansa Biopharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Fluoguide AS 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fluoguide AS are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Fluoguide unveiled solid returns over the last few months and may actually be approaching a breakup point.

Hansa Biopharma and Fluoguide Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hansa Biopharma and Fluoguide

The main advantage of trading using opposite Hansa Biopharma and Fluoguide positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hansa Biopharma position performs unexpectedly, Fluoguide can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fluoguide will offset losses from the drop in Fluoguide's long position.
The idea behind Hansa Biopharma AB and Fluoguide AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios